Medulloblastoma in Adolescents and Young Adults: Molecular Subgroups, Prognostic Biomarkers, and Age-Specific Therapeutic Challenges

Medulloblastoma is the most common malignant brain tumor in children, but it presents distinct challenges when occurring in adolescents and young adults (AYAs, aged 15–39 years). Recent molecular profiling has identified four principal medulloblastoma subgroups—WNT-activated, SHH-activated, Group 3,...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Antonio Ruggiero, Marco Gessi, Antonio d’Amati, Alessio Albanese, Giorgio Attinà
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2026-03-01
Saila:	Current Issues in Molecular Biology
Gaiak:	medulloblastoma adolescent and young adult molecular subgroups TP53 mutations MYCN amplification prognosis
Sarrera elektronikoa:	https://www.mdpi.com/1467-3045/48/3/297
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!